k.adeyemi
TL2 · Monterrey
Contributes reviews on supplier material. Based in Monterrey.
Joined 5 August 2025 · last posted 11h
75 posts, newest first. Showing up to 150.
-
Request: a per-category review queue Replied, post #136 · Meta › Feature requests · 27 Jul 2026 · 15 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
How much context is too much context in a first post? Replied, post #57 · Start Here › How to Ask · 9 Jul 2026 · 7 likes This follows post #54 rather than contradicting it. Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a…
-
Request: a per-category review queue Replied, post #68 · Meta › Feature requests · 29 Jun 2026 · 5 likes I would use that constantly. The objection is presumably that it is data the site then has to hold and protect for no benefit to anyone else.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #30 · Pharmacology › Receptor biology · 29 Jun 2026 · 0 likes Picking up post #27: that is the part I would want checked first. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #92 · Sourcing › Vendor reports · 28 Jun 2026 · 0 likes The arithmetic in post #89 is right; the assumption feeding it is the part to check. Do not adjust a reported figure. Post what the laboratory said and put your…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #37 · Compounds › Retatrutide · 26 Jun 2026 · 1 like What I can speak to on TRIUMPH is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #63 · Start Here › How to Ask · 22 Jun 2026 · 0 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #82 · Compounds › Semaglutide · 20 Jun 2026 · 0 likes Marking my uncertainty on molecular mass of semaglutide explicitly. I am confident about the direction, much less confident about the size, and not confident at all…
-
Tracking intake honestly when appetite is absent Replied, post #63 · Nutrition & Training › Protein & intake · 17 Jun 2026 · 0 likes Confirming post #62 from a second method, which matters more than confirming it from a second person. Marking my uncertainty on tracking intake explicitly. I am…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #29 · Evidence › Meta-analyses · 13 Jun 2026 · 14 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. Worth one more…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #57 · Practice › Reconstitution · 17 May 2026 · 18 likes I had written a reply contradicting post #53 and deleted it. Here is what survived. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
-
Batch numbers that do not match the vial label — what changed since Replied, post #10 · Sourcing › Red flags · 9 May 2026 · 0 likes On Batch numbers the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
About the N-of-1 designs category Replied, post #3 · Research Methods › N-of-1 designs · 5 May 2026 · 6 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #74 · Practice › Side effects · 29 Apr 2026 · 3 likes Agreed on Dizziness on standing, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #51 · Clinical › Bloodwork · 27 Apr 2026 · 25 likes Post #50 is right about the mechanism and I think understates the practical bit. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age,…
-
Journal club: is percentage weight change the right endpoint? Replied, post #105 · Evidence › Journal club · 26 Apr 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
Stepping down deliberately, and how to do it without losing progress Replied, post #96 · Practice › Dosing & titration · 21 Apr 2026 · 21 likes This is the answer, and the reason it is the answer is the more useful part.
-
Coming back to: Measurement error in a self-reported exposure Replied, post #4 · Evidence › Study critique · 19 Apr 2026 · 29 likes Narrowing post #2, because the general version has more than one answer. I think the Measurement error question is answerable and has not been answered, which is a more…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #81 · Analytics › Mass spectrometry · 14 Apr 2026 · 0 likes An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified backbone gives a mismatch that is not an error.
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #20 · Sourcing › Red flags · 22 Mar 2026 · 0 likes Worth separating two things that post #18 runs together. Being wrong in public about a supplier is costly to that supplier and to the person who was wrong. That is why…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Started this topic · Devices › Syringes & needles · 22 Mar 2026 · 0 likes 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters — setting out what I have, and where I think it stops being reliable. A follow-up question about 0.3 ml…
-
Second pass at: Identical chromatograms across two different lots Replied, post #66 · Sourcing › Red flags · 14 Mar 2026 · 0 likes Post #64 and I disagree about the size of the effect, not about the direction. My position on Identical chromatograms is current rather than settled. I have revised it…
-
Transporting a vial for a weekend away — a second dataset Replied, post #6 · Practice › Storage & stability · 12 Mar 2026 · 3 likes This is the sort of exchange that makes the archive worth searching.
-
Storing lyophilised material long term: what governs the shelf life Replied, post #89 · Practice › Storage & stability · 3 Mar 2026 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Worth one more sentence than it usually…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #26 · Practice › Administration · 27 Feb 2026 · 6 likes Picking up post #24: that is the part I would want checked first. The single most common technique error described here is drawing to the wrong graduation because the…
-
Second pass at: Identical chromatograms across two different lots Replied, post #4 · Sourcing › Red flags · 11 Feb 2026 · 25 likes Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #121 · Analytics › COA interpretation · 30 Jan 2026 · 16 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #18 · Evidence › Trials · 24 Jan 2026 · 7 likes Confirming post #16 from a second method, which matters more than confirming it from a second person. Risk of bias: structured appraisal of internal validity. Key…
-
Constipation management, with a dietitian's contribution Replied, post #14 · Practice › Side effects · 29 Dec 2025 · 4 likes Picking up post #13: that is the part I would want checked first. Something worth flagging about constipation management: the strongest-sounding claims in this thread…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #34 · Practice › Side effects · 27 Dec 2025 · 0 likes Building on post #31 rather than restating it. Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are…
-
Specification in the result column: why that is a meaningful error Replied, post #93 · Analytics › COA interpretation · 23 Dec 2025 · 5 likes No notes. Posting so the count is not one.
-
DXA precision and the least significant change for lean mass Replied, post #45 · Outcomes › Body composition · 5 Dec 2025 · 0 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #93 · Practice › Reconstitution · 26 Nov 2025 · 2 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
-
Pricing far outside the range, in either direction Replied, post #6 · marked as the solution · Sourcing › Red flags · 10 Nov 2025 · 9 likes On post #2 — agreed on the reasoning, with one qualification. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a…
-
Follow-up: Why appetite effects are mostly central Replied, post #89 · Pharmacology › Receptor biology · 7 Nov 2025 · 32 likes The area postrema sits outside the blood-brain barrier and is where a great deal of the nausea signalling in this class originates. That is why the effect is central…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #91 · Practice › Administration · 3 Oct 2025 · 0 likes This follows post #90 rather than contradicting it. Worth stating the null on pinch before we explain it: the observation may be nothing. That possibility deserves a…
-
Documentation that materially improves an appeal's chances Replied, post #14 · Access › Insurance & coverage · 30 Sep 2025 · 21 likes Where an exception process exists separately from an appeal, they are different routes with different criteria and using the wrong one loses time.
-
When to stop reading forums, including this one Replied, post #29 · Wellbeing › Mental health · 24 Sep 2025 · 27 likes Answering the question post #26 raises rather than the one it answers. Expectations set by other people's reported trajectories are a documented source of distress, and…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual Replied, post #5 · Compounds › Tirzepatide · 5 Sep 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Reading a supplier's product description as a marketing document Replied, post #64 · Compounds › Other compounds · 30 Aug 2025 · 2 likes Colour in a lyophilised cake is worth noting for the less common compounds specifically, because some of them are genuinely not white and a member expecting white will…
-
When a tidy document is a signal and when it is decoration Replied, post #9 · Analytics › COA interpretation · 30 Aug 2025 · 0 likes The question underneath tidy document is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #82 · Evidence › Trials · 28 Aug 2025 · 7 likes Sample size calculations is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #27 · Compounds › Oral incretins · 20 Aug 2025 · 22 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #7 · Practice › Side effects · 20 Aug 2025 · 5 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
A request that was declined, and the reasoning — a second dataset Replied, post #65 · Documentation › Wiki requests · 12 Aug 2025 · 0 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #54 · Data & Tools › Calculators · 17 Jul 2025 · 13 likes I read post #50 twice before replying, because I had assumed the opposite. A saved calculation is worth more than a remembered one. Write down the inputs alongside the…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #37 · Devices › Syringes & needles · 17 Jul 2025 · 8 likes Something worth flagging about Filter needles: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #30 · Analytics › Home & field testing · 24 Jun 2025 · 15 likes I had written a reply contradicting post #28 and deleted it. Here is what survived. Where the quantitation discussion usually stalls is that nobody wants to say "I do…
-
Interpreting a composition change that is within the error bars Replied, post #6 · Outcomes › Body composition · 21 Jun 2025 · 3 likes Helpful, and short, which on this subject is harder than long.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #60 · Access › Insurance & coverage · 11 Jun 2025 · 19 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #93 · Clinical › Comorbidities · 23 May 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Pregnancy as an absolute contraindication Replied, post #2 · Safety › Contraindications · 16 May 2025 · 0 likes Personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2, is the clearest contraindication in this class and it is specific…
-
Specification in the result column: why that is a meaningful error Started this topic · Analytics › COA interpretation · 14 May 2025 · 35 likes Posting this under the heading it deserves: Specification in the result column: why that is a meaningful error Everything below is what sits behind that. A…
-
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Replied, post #2 · Compounds › Tirzepatide · 11 May 2025 · 23 likes The opening post describes the usual case. This is about the unusual one. Comparisons between the tirzepatide and semaglutide programmes across trials rather than…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #109 · Evidence › Journal club · 3 May 2025 · 3 likes I have been on both sides of the SURMOUNT-1 argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Revisiting: German, French and Dutch differences, compared Replied, post #15 · Regional › European Union · 25 Apr 2025 · 15 likes Post #13 and I disagree about the size of the effect, not about the direction. Practical experience of German, offered as one case with the conditions stated, not as a…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #4 · Clinical › Bloodwork · 7 Apr 2025 · 3 likes This is the answer, and the reason it is the answer is the more useful part.
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #28 · Compounds › Secretagogues & GH axis · 21 Mar 2025 · 22 likes On post #24 — agreed on the reasoning, with one qualification. Two people in this thread mean different things by Tesamorelin and are disagreeing about the definition…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #70 · Analytics › COA interpretation · 11 Mar 2025 · 0 likes Answering the question post #66 raises rather than the one it answers. One more thing on Counter-ion form that took me far too long to see: the two figures people quote…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #64 · Pharmacology › Receptor biology · 9 Mar 2025 · 21 likes Post #60 put the caveat in the right place and I want to underline it. Biased agonism — where different ligands at the same receptor favour different downstream…
-
Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 18 Feb 2025 · 30 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #17 · Compounds › Secretagogues & GH axis · 5 Jan 2025 · 0 likes On post #15 — agreed on the reasoning, with one qualification. Published human data on most of this family is thin, old, or from small studies with surrogate endpoints.…
-
When to suspect the method rather than the sample Replied, post #54 · Analytics › Method validation · 22 Dec 2024 · 4 likes Linearity across the working range is a routine demonstration and it constrains how far a result can be extrapolated. A method linear from 80 to 120 per cent of nominal…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #26 · Compounds › Semaglutide · 21 Dec 2024 · 6 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Second pass at: A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #4 · Devices › Pens & autoinjectors · 21 Dec 2024 · 22 likes Reading rather than answering, but this is the post I would point somebody at.
-
Coming back to: When to suspect the method rather than the sample Replied, post #53 · Analytics › Method validation · 10 Dec 2024 · 24 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #48 · Access › Insurance & coverage · 30 Nov 2024 · 4 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
A well-designed study with a badly written abstract — does this still hold? Replied, post #3 · marked as the solution · Evidence › Study critique · 16 Nov 2024 · 7 likes Reporting bias within a paper — a result in a figure that is absent from the abstract — is checkable and is worth checking when the claim matters. The reasoning is more…
-
When "no data" is the complete and final answer Replied, post #12 · Compounds › Other compounds · 31 Oct 2024 · 6 likes Post #11 answers the question as asked. The question underneath it is different. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #64 · Compounds › Other compounds · 21 Oct 2024 · 0 likes Worth separating Melanocortin agonists as a question about the compound from Melanocortin agonists as a question about the documentation. They get answered by different…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #124 · Clinical › Bloodwork · 19 Oct 2024 · 11 likes The most useful thing this subcategory does is help people tell an interesting result from an uninteresting one before booking an appointment about it. Worth one more…
-
Requesting a page: what makes a good request — what changed since Replied, post #22 · Documentation › Wiki requests · 9 Oct 2024 · 0 likes Worth separating two things that post #19 runs together. A calculator request and a document request are different things, and a calculator without a document…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #16 · Practice › Administration · 8 Sep 2024 · 4 likes Answering the question post #13 raises rather than the one it answers. Where the site rotation scheme reasoning breaks down for me is the step from the group result to…
-
Chronic kidney disease and the FLOW result Replied, post #32 · Clinical › Comorbidities · 21 Aug 2024 · 12 likes What I would want before treating chronic kidney disease as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
-
Assessing a warm arrival: the decision process — one year on Started this topic · Sourcing › Logistics · 27 May 2024 · 42 likes Assessing a warm arrival: the decision process — one year on Writing it up because I had to work it out twice and would rather nobody else did. An honest uncertainty…